Key result
MMP-3 5A/6A and MMP-9 -1562C→T polymorphisms linked to up to ~21% greater MI risk.
Why the study?
The literature provides no clear answer as to whether matrix metalloproteinases polymorphisms increase risk of myocardial infarction.
Do matrix metalloproteinases (MMPs) polymorphisms increase the risk of myocardial infarction?
Meta-Analysis
Do matrix metalloproteinases (MMPs) polymorphisms increase the risk of myocardial infarction?
Odds Ratio: 1.21 (95% CI 1.01–1.46)
p-value: p=0.04
MMP-3 5A/6A and MMP-9 -1562 C→T polymorphisms are genetic risk factors associated with increased susceptibility to myocardial infarction, with variations across ethnic populations.
MMP-3/MMP-9 variants may elevate MI risk; extends genetic association evidence but should not yet change practice.
CONTEXT: The literature provides no clear answer as to whether matrix metalloproteinases (MMPs) polymorphisms increases risk of myocardial infarction (MI). OBJECTIVE: Our purpose was to help clarify the inconsistent findings of MMPs polymorphisms and MI susceptibility and identify which MMP polymorphism might play an active role in the occurrence of MI. DATA SOURCES: Articles were identified by a Medline search and citation tracking. STUDY SELECTION: Eligible articles were case-control studies of MMPs polymorphisms and MI which met our prespecified criteria. DATA EXTRACTION: Data were independently extracted by two authors according to a predefined protocol. Incongruities were settled by consensus decision. RESULTS AND CONCLUSIONS: 18 potentially eligible articles were identified. In a combined analysis, the 5A allele of the MMP-3 5A/6A polymorphism was associated with MI (OR 1.21, 95% CI 1.01 to 1.46, p=0.04), suggesting its role in plaque rupture. In the subgroup analysis by ethnicity, significantly increased risk was found among East Asians (OR 1.39, 95% CI 1.01 to 1.91, p=0.04), whereas no significant association was detected in Caucasian populations. In addition, there were significant associations of the MMP-9 -1562C→T polymorphism with MI (OR 1.14, 95% CI 1.02 to 1.27, p=0.02), whereas the heterogeneity of the studies showed no significance (I(2)=13.7%, p=0.32). This meta-analysis demonstrated that the MMP-3 5A/6A and MMP-9 -1562 C→T polymorphisms are risk factors associated with increased MI susceptibility, but these associations vary in different ethnic populations.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2011) conducted a meta-analysis in myocardial infarction. MMP-3 5A/6A polymorphism was evaluated on myocardial infarction (OR 1.21, 95% CI 1.01 to 1.46, p=0.04). The MMP-3 5A/6A (OR 1.21; 95% CI 1.01-1.46) and MMP-9 -1562C→T (OR 1.14; 95% CI 1.02-1.27) polymorphisms were significantly associated with increased susceptibility to myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: